These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5325716)

  • 1. [Prevention of vascular lesions in arterial hypertension].
    Milliez P; Lagrue G; Meyer P
    Bull Inst Natl Sante Rech Med; 1966; 21(1):7-23. PubMed ID: 5325716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-medication prevention of vascular complications in mild arterial hypertension].
    Aleksandrov AA; Martianova II; Nebieridze DV
    Sov Med; 1988; (12):35-9. PubMed ID: 3071865
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempted prevention of arteriolar lesions in accelerated rat hypertension by immunosuppression.
    Gardner DL; Quagliata F; Drossman M; Kalish M; Schimmer B
    Br J Exp Pathol; 1970 Jun; 51(3):242-52. PubMed ID: 5429071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
    Yamamoto E; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Lai ZF; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):556-63. PubMed ID: 17170375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of anatomic control in the training of the vascular system for gravitational overloading].
    Prives MG; Bardina RA; Eremin ; Stepantsov VI; Kosourov AK
    Arkh Anat Gistol Embriol; 1969 Oct; 57(10):13-7. PubMed ID: 5379608
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of hypertensive vasculopathy by nifedipine in salt-loaded Dahl rats.
    Luckhaus G; Garthoff B; Kazda S
    Arzneimittelforschung; 1982; 32(11):1421-5. PubMed ID: 6891246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural changes in hypertension, the potential for their prevention, arrest and reversal: a focus on felodipine.
    Purcell H; Coats A
    Br J Clin Pract; 1994; 48(6):311-6. PubMed ID: 7848795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension management in patients with vascular disease.
    Kohlman-Trigoboff D
    J Vasc Nurs; 2004 Jun; 22(2):53-6. PubMed ID: 15179419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular disease, hypertension, and prevention.
    Lavie CJ
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):19A-22A. PubMed ID: 15261686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and therapy of ischemic tissue lesions. Stage IV of arterial occlusive disease].
    Hild R
    Dtsch Med J; 1967 May; 18(10):329-32. PubMed ID: 5612098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hypertension complicated by peripheral vascular disease].
    Ebihara A; Ashida T
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():321-4. PubMed ID: 11028349
    [No Abstract]   [Full Text] [Related]  

  • 12. Consensus statement for the prevention of vascular disease.
    National Vascular Disease Prevention Alliance
    Aust Fam Physician; 2004 Apr; 33(4):235-9. PubMed ID: 15129468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a causative role of adrenocortical activity in the genesis of disseminated arterial lesions induced in rabbits by renal alterations.
    Santos-Buch CA; Murphy GE; Becker CG; Miscall BG; Campbell WG
    Lab Invest; 1966 Aug; 15(8):1327-41. PubMed ID: 5920362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early lesions of cerebral atherosclerosis from induced hypertension in Watanabe heritable hyperlipidemic rabbits.
    Kong J; Tamaki N; Asada M
    Kobe J Med Sci; 2000 Apr; 46(1-2):87-101. PubMed ID: 11193506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between renin activity and vascular complications of arterial hypertension].
    Bonfanti F; Pecci R; Nortilli R; Brugnara C; Corrocher R
    Minerva Cardioangiol; 1982 Mar; 30(3):75-80. PubMed ID: 7045721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of vasopressin in arterial hypertension].
    Thibonnier M; Sassano P; Daufresne S; Menard J
    Nouv Presse Med; 1982 Oct; 11(39):2915-20. PubMed ID: 7145678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronobiology in hemodynamic imbalance syndromes and in the prevention of vascular diseases].
    Marconi G; Pappalettera N; Modoni F; Tamburrino G
    Minerva Med; 1982 Apr; 73(16):983-1046. PubMed ID: 7078794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension and vascular risk factors. Need for a multifactorial approach].
    Lagrue G
    Soins; 1982 Feb; 27(4):3-4. PubMed ID: 6918146
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arterial hypertension as a risk factor for hemifacial spasm due to vascular compression].
    Ioli P; Vera J; Femminini R; Gonorazky SE
    Rev Neurol; 2004 Jul 16-31; 39(2):198-9. PubMed ID: 15264174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.